June 10, 2020 Price forecast | 2 weeks: 2.25% | 1 month: -1.55% | 3 months: -5.53%


ARCT stock forecast

Our latest prediction for Arcturus Therapeutics Holdings, Inc.'s stock price was made on the June 10, 2020 when the stock price was at 31.55$.

In the short term (2weeks), ARCT's stock price should outperform the market by 2.25%. During that period the price should oscillate between -10.82% and +13.29%.

In the medium term (3months), ARCT's stock price should underperform the market by -5.53%. During that period the price should oscillate between -37.15% and +29.28%.

Create a solid portfolio with ARCT

Add ARCT to your portfolio and optimize it!


About Arcturus Therapeutics Holdings, Inc.

Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.

At the moment the company generates 11M USD in revenues.

On its last earning announcement, the company reported a loss of -2.61$ per share.

The book value per share is 0.48$

Arcturus Therapeutics Holdings, Inc. website


Three months stock forecastJune 10, 2020


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
11M - -38M -337.10% -38M -2.61 - - 15M 0.48 -31M -1M -32M